BoneSurg HA is a novel, nanocrystalline hydroxyapatite (nHA) bone graft material designed for easy and complete filling of bone defects, such as those following High Tibial Osteotomy. Approved by CDSCO, its chemical and crystalline structure promotes natural bone remodelling, while its excellent biocompatibility ensures the surrounding tissue tolerates it well.
A novel bone graft material based on nanocrystalline Hydroxyapatite nHA for superior defect filling.
High surface area and composition promote tissue growth and act as a scaffold for bone formation.
Approved by the Central Licensing Authority for use as a bone defect filler.
Well-tolerated by surrounding tissue, the solid substance quickly and fully incorporates into the bone.
BoneSurg HA's 50 nm nanocrystals reduce cell apoptosis and inflammation, accelerating bone formation and patient recovery post-surgery.
Open-wedge high tibial osteotomy (OWHTO) is a very common surgical technique for the treatment of knees with varus malalignment. Correcting the lower limb axis creates a gap on the tibia which can be filled with nanocrystalline hydroxyapatite (BoneSurg HA) to give an optimum support. Healing of that part is an important issue, since its delay or nonunion may result in loss of correction.
BoneSurg HA mimics human bone composition, offering high biocompatibility and a large surface area due to its nano-size, making it an ideal bone void filler with high union rates.
Resorbable bone replacements are formed by the rapid growth of bone tissue. Nanohydroxyapatite (nHA) has been shown to hasten bone remodelling and development, enabling the patient to resume full weight bearing sooner following OWHTO. Autologous iliac crest has long been considered the gold standard for bone grafting due to its high union rate, structural qualities, and potential for osteoconductive and osteoinductive growth. Furthermore, it is generally known that hydroxyapatite, which makes up bone mineral, is shaped like a needle or a rod and that its crystals are incredibly small, with an average length of 50 nm. When BoneSurg HA was mixed with cancellous bones, osteoblast cell proliferation was enhanced, cell apoptosis was inhibited, and macrophage inflammation was reduced.
